Premium Only Content

HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases with unmet medical needs. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryte™, a novel photodynamic therapy that uses safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). The Company has successfully completed a Phase 3 study for HyBryte™ and is now negotiating a confirmatory Phase 3 pivotal study design with the US Food & Drug Administration, while also evaluating/pursuing potential HyBryte™ marketing approval ex-U.S. with the successfully completed Phase 3 study. Visit SNGXinfo.com to learn more.
-
2:47:03
Patriot Underground
17 hours agoTruthStream RT w/ Joe & Scott (7.30.25 @ 5PM EST)
25.1K24 -
11:25
Nikko Ortiz
13 hours agoMost Painful Fails
13.1K23 -
16:23
GritsGG
13 hours agoWorld Record Call of Duty Win Streak Attempting!
3.16K1 -
2:02:54
Side Scrollers Podcast
18 hours agoJOEY SWOLL/HULK HOGAN CONTROVERSY + ONLINE SAFETY ACT + MORE | SIDE SCROLLERS
25.9K2 -
1:05:44
Omar Elattar
9 months agoThe Digital Real Estate Expert: You're Being Lied To About Making Money Online!
4.61K -
10:53
Nikko Ortiz
2 days agoWORST Clips On The Internet
86K27 -
3:42:38
FreshandFit
13 hours agoREAL R*pe Victim Exposes Shannon Sharpe Accuser As Liar!
70.1K80 -
2:18:29
Badlands Media
15 hours agoDevolution Power Hour Ep. 376: Optics, Explosions & the War for the Narrative
144K43 -
37:46
Stephen Gardner
13 hours ago🔥Trump NEVER expected THIS WIN as Schumer has EPIC MELTDOWN!
44K34 -
2:02:41
Inverted World Live
9 hours agoNASA Engineer Says Trillions of Shape-Shifting, Cloaked Devices are Hidden on Earth| Ep. 83
39K11